Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Verkkopohjainen ohjelma, joka auttaa keuhkopotilaiden hoitajia oppimaan saatavilla olevista tukihoitoresursseista (CONNECT)

keskiviikko 23. syyskuuta 2026 päivittänyt: Wake Forest University Health Sciences

Monipaikkainen yhteisön onkologiasuunnittelu CONNECT-intervention kohdentamiseksi keuhkosyövän hoitajille

Clinical trial that tests the feasibility of a web based caregiver support resource, along with caregiver navigation sessions for caregivers of patients with stage II-IV lung cancer. The Caregiver Oncology Needs Evaluation Tool (CONNECT) is a novel web-based intervention designed for the community oncology setting, to systematically connect lung cancer caregivers with tailored supportive care resources. Lung cancer caregivers provide critical and challenging care for their loved ones and are at risk for their own negative psychosocial and physical outcomes. Implementing the CONNECT program along with caregiver navigation may provide additional support to caregivers of patients with stage II-IV lung cancer.

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

This study is a multi-site randomized pilot trial enrolling 120 lung cancer caregiver-patient dyads (i.e., lung cancer caregivers (n=120) and their care-recipients (n=120)) across approximately 8-12 practices to assess the multi-site feasibility of a caregiver technology-based intervention (CONNECT) to identify caregivers' needs and connect them with supportive care resources. Caregivers will be randomized 1:1:1 to either the CONNECT intervention, usual care comparison group or generic resource list comparison group. CONNECT is a web-based intervention that empowers and educates caregivers about the benefits of supportive care services and systematically identifies unmet needs to connect lung cancer caregivers with tailored supportive care resources. The Central Caregiver Navigator will assist caregivers with resolving barriers to accessing resources and work with the Local Practice Referral Coordinator to process referrals. Caregivers and patients will complete measures at baseline (prior to caregiver randomization), and 12 and 24 weeks after baseline. Feasibility measures (retention, accrual rates, and participation) will be evaluated to inform the future trial. The Local Practice Referral Coordinator for each practice will report on time needed for practice participation, referral processes, and communication processes with the Central Caregiver Navigator.

Participants (i.e., patients or care-recipients) will be asked to complete study surveys at three time points:

  • After consenting and before randomization of participant and caregiver. (Initial survey)
  • Approximately 12 weeks after completing the first survey (12-week survey)
  • Approximately 24 weeks after completing the first survey (24-week survey)

Each survey will take about 30-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), cancer symptoms, satisfaction with cancer care and health behaviors. You don't have to answer any question that makes you feel uncomfortable. These surveys can be done remotely over the internet, in the clinic, by phone or by mail.

Caregivers will also complete surveys at three time points and will be assigned to 1 of 3 study groups:

  • Group 1 will be given the usual care provided at your clinic. At the completion of the study, this group will be given the generic supportive care resource list for their use that Group 2 received.
  • Group 2 will be provided with a generic supportive care resource list.
  • Group 3 will be asked to watch a brief video and complete the web-based CONNECT program either in the clinic or on your own device. The CONNECT program is designed to help identify any unmet needs and connect the caregiver with tailored supportive care resources, based on specific needs. The CONNECT Navigator will follow-up with within 2 business days of completion of the program and again 4 weeks later.

Caregiver Participants (Group 1, 2 and 3) will be asked to complete study surveys at three time points:

  • After consenting and before randomization of participant and caregiver. (Initial survey)
  • Approximately 12 weeks after completing the first survey (12-week survey)
  • Approximately 24 weeks after completing the first survey (24-week survey)

Each survey will take about 35-45 minutes to complete. The forms will ask about things such as demographics (sex, race, etc.), caregiving experience, use of supportive care resources, quality of life, mood, and social needs (housing, transportation, utilities, etc). You don't have to answer any question that makes you feel uncomfortable.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

216

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

    • Colorado
      • Denver, Colorado, Yhdysvallat, 80205
        • Kaiser Permanente-Franklin
      • Lafayette, Colorado, Yhdysvallat, 80026
        • Kaiser Permanente - Rock Creek
      • Lone Tree, Colorado, Yhdysvallat, 80124
        • Kaiser Permanente - Lone Tree
    • Delaware
      • Millville, Delaware, Yhdysvallat, 19967
        • Beebe South Coastal Health Campus
      • Rehoboth Beach, Delaware, Yhdysvallat, 19971
        • Beebe Health Campus
    • Georgia
      • Augusta, Georgia, Yhdysvallat, 30912
        • Augusta University Medical Center
    • Hawaii
      • Honolulu, Hawaii, Yhdysvallat, 96813
        • Hawaii Cancer Care Inc - Waterfront Plaza
      • ‘Aiea, Hawaii, Yhdysvallat, 96701
        • Hawaii Cancer Care - Westridge
    • Missouri
      • Osage Beach, Missouri, Yhdysvallat, 65065
        • Lake Regional Hospital
      • Springfield, Missouri, Yhdysvallat, 65807
        • CoxHealth South Hospital
    • New York
      • The Bronx, New York, Yhdysvallat, 10461
        • Montefiore Medical Center-Einstein Campus
    • North Carolina
      • Winston-Salem, North Carolina, Yhdysvallat, 27157
        • Wake Forest NCORP Research Base
    • Pennsylvania
      • Scranton, Pennsylvania, Yhdysvallat, 18510
        • Community Medical Center
      • Wilkes-Barre, Pennsylvania, Yhdysvallat, 18711
        • Geisinger Wyoming Valley/Henry Cancer Center
    • South Carolina
      • Gaffney, South Carolina, Yhdysvallat, 29341
        • Gibbs Cancer Center-Gaffney
      • Greenville, South Carolina, Yhdysvallat, 29615
        • Prisma Health Cancer Institute - Eastside
      • Greenville, South Carolina, Yhdysvallat, 29605
        • Prisma Health Cancer Institute - Butternut
      • Greer, South Carolina, Yhdysvallat, 29651
        • Gibbs Cancer Center-Pelham
      • Spartanburg, South Carolina, Yhdysvallat, 29303
        • Spartanburg Medical Center
      • Union, South Carolina, Yhdysvallat, 29379
        • MGC Hematology Oncology-Union
    • Wisconsin
      • Appleton, Wisconsin, Yhdysvallat, 54911
        • ThedaCare Regional Cancer Center
      • Green Bay, Wisconsin, Yhdysvallat, 54311
        • Aurora BayCare Medical Center
      • Kenosha, Wisconsin, Yhdysvallat, 53142
        • Aurora Cancer Care-Kenosha South
      • Milwaukee, Wisconsin, Yhdysvallat, 53215
        • Aurora Saint Luke's Medical Center
      • Neenah, Wisconsin, Yhdysvallat, 54956
        • ThedaCare Regional Medical Center - Neenah

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta ja vanhemmat (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Patient Inclusion Criteria:

  • Must be ≥ 18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must have a current diagnosis of new (i.e., initial diagnosis) or recurrent stage II-IV lung cancer
  • Must be enrolled after the start of anticancer systemic therapy (+/- radiation therapy) with at least 9 weeks of any planned anticancer treatment remaining
  • Must be ambulatory and up (i.e., not bedridden) more than 50% of waking hours
  • Must self-report receiving informal (i.e., not professional) care from a caregiver who meets the study caregiver criteria and who is willing to participate

Caregiver Inclusion Criteria:

  • Must be ≥18 years of age, as this study is focused on the experience of adult patient-caregiver dyads
  • Must self-report providing informal (i.e. not professional) care during cancer treatment for a patient who meets the patient criteria and who is willing to participate
  • Must have access to the internet at home or be willing to use CONNECT in the clinic
  • Must have access to telephone to complete sessions with the central caregiver navigator

Patient Exclusion Criteria:

  • Patients who have completed treatment for their lung cancer at the time of study enrollment
  • Enrolled in hospice care
  • Unable to read and English and not willing to have someone read surveys for them

Caregiver Exclusion Criteria:

  • Self-report currently receiving cancer treatment
  • Unable to read and communicate in English, as the CONNECT intervention is currently only available in English

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Tukevaa hoitoa
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Active Comparator: Group 1 (Standard care followed by generic resource list)

Caregivers receive standard care and are then given a generic resource list at week 24.

Receive a generic resource list

Active Comparator: Group 2 (Generic resource list)

Caregiver receive a generic resource list at the start of the study.

Receive a generic resource list

Kokeellinen: Group 3 (CONNECT, personalized list, and navigation)

Caregivers receive access to the CONNECT tool, watch an educational video on self care and receive a personalized list of resources based on caregiver preferences. Caregivers also receive access to and complete at least 2 calls, at baseline and at week 4, with a caregiver navigator to review the resource list and address any additional needs.

Receive personalized resource list

Receive access to CONNECT tool

Complete calls with caregiver navigator

Muut nimet:
  • Potilasnavigaattoriohjelma

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Caregiver retention at 12 weeks
Aikaikkuna: At 12 weeks

Calculated as the following: Number of caregivers who complete at least 75% of the 12-week assessments divided by the number randomized. Retention will be estimated and reported along with an exact 95% confidence interval.

At 12 weeks

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Caregiver accrual rate
Aikaikkuna: Upon completion of recruitment, approximately 12 months

Number of caregivers who agree to participate divided by the number of months of recruitment

Upon completion of recruitment, approximately 12 months
Caregiver participation
Aikaikkuna: Upon completion of recruitment, approximately 12 months

Proportion of eligible caregivers who agreed to participate

Upon completion of recruitment, approximately 12 months
Caregiver retention at 24 weeks
Aikaikkuna: At 24 weeks

Number of caregivers who complete at least 75% of the 24-week assessments divided by the number randomized.

At 24 weeks
Caregiver acceptability
Aikaikkuna: At 12 weeks

Self-report survey developed for this study to assess the degree to which caregivers found different aspects of CONNECT, the generic resource list, or usual care helpful using a Likert response from 0 (Not at all) to 5 (Very Much)

At 12 weeks
Average time (minutes) needed for training for Local Practice Referral Coordinator
Aikaikkuna: At completion of training, up to 6 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

At completion of training, up to 6 months
Desired modality for training (e.g., live webinar, recorded video, paper materials) for Local Practice Referral Coordinator
Aikaikkuna: At completion of training, up to 6 months

Will be summarized using appropriate descriptive statistics.

At completion of training, up to 6 months
Average time (minutes) needed to identify and enter local resources into the Caregiver Oncology Needs Evaluation Tool (CONNECT) database
Aikaikkuna: At conclusion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

At conclusion of practice intervention activities, an average of 18 months
Frequency of needed resource updates in the CONNECT database
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range

Up to completion of practice intervention activities, an average of 18 months
Average time (minutes) spent by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Modality of contact (e.g. phone, virtual web meeting, email) made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Number of contacts made by the Central Caregiver Navigator and Local Practice Referral Coordinators with each caregiver in the CONNECT arm
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Number of referrals facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Type of referrals (e.g., in person, online) facilitated by the Local Practice Referral Coordinator and Central Caregiver Navigator
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Average time (minutes) needed to communicate for Central Caregiver Navigator and Local Practice Referral Coordinator
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized across practices using mean, median, standard deviation and interquartile range.

Up to completion of practice intervention activities, an average of 18 months
Modalities used for communication (e.g., phone, virtual web meeting, email) for Central Caregiver Navigator and Local Practice Referral Coordinator
Aikaikkuna: Up to completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

Up to completion of practice intervention activities, an average of 18 months
Improvements for the future trial from Local Practice Referral Coordinator's perspectives from a survey at the end of the study
Aikaikkuna: At completion of practice intervention activities, an average of 18 months

Will be summarized using appropriate descriptive statistics.

At completion of practice intervention activities, an average of 18 months

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Patient accrual rate
Aikaikkuna: Upon completion of recruitment, approximately 12 months

Number of patients who agree to participate divided by the number of months of recruitment

Upon completion of recruitment, approximately 12 months
Patient participation rate
Aikaikkuna: Upon completion of recruitment, approximately 12 months

Proportion of eligible patients who agreed to participate

Upon completion of recruitment, approximately 12 months
Patient retention at 12 weeks
Aikaikkuna: At 12 weeks

Number of patients who complete at least 75% of the 12-week assessments divided by the number randomized

At 12 weeks
Patient retention at 24 weeks
Aikaikkuna: At 24 weeks

Number of patients who complete at least 75% of the 24-week assessments divided by the number randomized

At 24 weeks

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Yhteistyökumppanit

Tutkijat

  • Opintojen puheenjohtaja: Kathryn Weaver, PhD, Wake Forest University Health Sciences

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 11. marraskuuta 2024

Ensisijainen valmistuminen (Arvioitu)

Keskiviikko 30. joulukuuta 2026

Opintojen valmistuminen (Arvioitu)

Keskiviikko 30. joulukuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Maanantai 15. huhtikuuta 2024

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Maanantai 22. huhtikuuta 2024

Ensimmäinen Lähetetty (Todellinen)

Torstai 25. huhtikuuta 2024

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 25. syyskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 23. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

JOO

IPD-suunnitelman kuvaus

Wake Forest NCORP Research Base is committed to following the NIH Statement on Sharing Research Data (http://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html). As of July 2018, the WF NCORP RB signed an agreement with NCI to contribute de-identified data and data dictionaries from clinical trials conducted through our RB to the NCI NCTN/NCORP data archive within 6 months of primary and non-primary publications of phase II/III and phase III trials to https://nctn-data-archive.nci.nih.gov/. This will become the primary means for sharing raw data, and we will adhere to the guidelines spelled out in the NCTN/NCORP Data Archive Usage Guide. De-identified data from studies not covered by the agreement (e.g., phase II and observational studies) will be made available upon request. All data files will be de-identified. De-identification procedures will meet the HIPAA criteria as detailed in the Code of Federal Regulations, Part 45, Section 164.514.

IPD-jaon aikakehys

6 months after publication for a 2 year duration

IPD-jaon käyttöoikeuskriteerit

upon request to NCORP@wakehealth.edu

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa